{"id":"https://openalex.org/W2018710752","doi":"https://doi.org/10.1097/cji.0b013e3181587977","title":"Phase I/II Trial of Outpatient PEG-interferon With Interleukin-2 in Advanced Renal Cell Carcinoma: A Cytokine Working Group Study","display_name":"Phase I/II Trial of Outpatient PEG-interferon With Interleukin-2 in Advanced Renal Cell Carcinoma: A Cytokine Working Group Study","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2018710752","doi":"https://doi.org/10.1097/cji.0b013e3181587977","mag":"2018710752","pmid":"https://pubmed.ncbi.nlm.nih.gov/18049336"},"language":"en","primary_location":{"id":"doi:10.1097/cji.0b013e3181587977","doi":"https://doi.org/10.1097/cji.0b013e3181587977","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0b013e3181587977","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034792001","display_name":"Joseph I. Clark","orcid":"https://orcid.org/0000-0002-0455-2625","observed_orcids":["https://orcid.org/0000-0002-0455-2625"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joseph I. Clark","raw_affiliation_strings":["*Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA. jclark@lumc.edu","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA. jclark@lumc.edu","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016686264","display_name":"Jessica Mehrabi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jessica Mehrabi","raw_affiliation_strings":["Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Sosman","raw_affiliation_strings":["Vanderbilt University, Nashville, TN","Vanderbilt University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Vanderbilt University","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103165801","display_name":"Theodore F. Logan","orcid":"https://orcid.org/0000-0002-9245-0820","observed_orcids":["https://orcid.org/0000-0002-9245-0820"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodore F. Logan","raw_affiliation_strings":["Indiana University, Indianapolis, IN","Indiana University-Purdue"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]},{"raw_affiliation_string":"Indiana University-Purdue","institution_ids":["https://openalex.org/I592451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084347950","display_name":"Kim Allyson Margolin","orcid":"https://orcid.org/0000-0002-5248-4356","observed_orcids":["https://orcid.org/0000-0002-5248-4356","https://orcid.org/0000-0002-5718-7422"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim A. Margolin","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, CA","City of Hope National Med Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]},{"raw_affiliation_string":"City of Hope National Med Center","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033346506","display_name":"Janice P. Dutcher","orcid":"https://orcid.org/0000-0002-2267-9187","observed_orcids":["https://orcid.org/0000-0002-2267-9187"]},"institutions":[{"id":"https://openalex.org/I19772626","display_name":"Yeshiva University","ror":"https://ror.org/045x93337","country_code":"US","type":"education","lineage":["https://openalex.org/I19772626"]},{"id":"https://openalex.org/I4210119873","display_name":"Lady of Mercy Medical Center","ror":"https://ror.org/02navrb60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626","https://openalex.org/I4210119873"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janice P. Dutcher","raw_affiliation_strings":["Our Lady of Mercy Medical Center, Bronx, NY","Yeshiva University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Our Lady of Mercy Medical Center, Bronx, NY","institution_ids":["https://openalex.org/I4210119873"]},{"raw_affiliation_string":"Yeshiva University","institution_ids":["https://openalex.org/I19772626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025100380","display_name":"Walter John Urba","orcid":"https://orcid.org/0000-0001-8414-3348","observed_orcids":["https://orcid.org/0000-0001-8414-3348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter J. Urba","raw_affiliation_strings":["Earle A. Chiles Research Institute, Portland, OR","Earle A. Chiles Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute, Portland, OR","institution_ids":[]},{"raw_affiliation_string":"Earle A. Chiles Research Institute","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089516753","display_name":"Marc S. Ernstoff","orcid":"https://orcid.org/0000-0002-8132-7069","observed_orcids":["https://orcid.org/0000-0002-8132-7069"]},"institutions":[{"id":"https://openalex.org/I1289422878","display_name":"Dartmouth\u2013Hitchcock Medical Center","ror":"https://ror.org/00d1dhh09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I107672454","https://openalex.org/I1289422878","https://openalex.org/I4390039337"]},{"id":"https://openalex.org/I4390039367","display_name":"Dartmouth Cancer Center","ror":"https://ror.org/044b05b34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039367"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc S. Ernstoff","raw_affiliation_strings":["Dartmouth Hitchcock Cancer Center, Lebanon, NH","Dartmouth Hitchcock Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dartmouth Hitchcock Cancer Center, Lebanon, NH","institution_ids":["https://openalex.org/I1289422878","https://openalex.org/I4390039367"]},{"raw_affiliation_string":"Dartmouth Hitchcock Cancer Center","institution_ids":["https://openalex.org/I1289422878","https://openalex.org/I4390039367"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David F. McDermott","raw_affiliation_strings":["Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","Harvard University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"Harvard University","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079178079","display_name":"Ann M. Lau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ann M. Lau","raw_affiliation_strings":["Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","#N#        Loyola University, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"#N#        Loyola University, Chicago","institution_ids":["https://openalex.org/I1925986"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","Harvard University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL","institution_ids":["https://openalex.org/I1925986"]},{"raw_affiliation_string":"Harvard University","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5007052233","https://openalex.org/A5016686264","https://openalex.org/A5034792001","https://openalex.org/A5052526230","https://openalex.org/A5079178079"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I1925986"],"apc_list":null,"apc_paid":null,"fwci":0.2881,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.67649806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"30","issue":"8","first_page":"839","last_page":"846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9879999756813049},{"id":"https://openalex.org/keywords/advanced-renal-cell-carcinoma","display_name":"advanced renal cell carcinoma","score":0.828000009059906},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cytokine-therapy","display_name":"cytokine therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9160000085830688},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.414000004529953},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6439999938011169},{"id":"https://openalex.org/keywords/neurologic-toxicity","display_name":"neurologic toxicity","score":0.9769999980926514},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7120000123977661},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.5699999928474426},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.889550507068634},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6109477281570435},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5801887512207031},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5628702640533447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5105117559432983},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4138229489326477},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4119386076927185},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.41124778985977173},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4079747498035431},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010045","descriptor_name":"Outpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058186","descriptor_name":"Acute Kidney Injury","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cji.0b013e3181587977","doi":"https://doi.org/10.1097/cji.0b013e3181587977","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0b013e3181587977","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:18049336","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18049336","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1222874231","https://openalex.org/W1497476164","https://openalex.org/W1875468008","https://openalex.org/W1904017285","https://openalex.org/W1915939031","https://openalex.org/W1941542407","https://openalex.org/W1942070062","https://openalex.org/W1967708299","https://openalex.org/W1975916906","https://openalex.org/W1985269587","https://openalex.org/W2062341818","https://openalex.org/W2098136315","https://openalex.org/W2119543617","https://openalex.org/W2123914905","https://openalex.org/W2142337801","https://openalex.org/W2143813821","https://openalex.org/W2171469612","https://openalex.org/W2173123780","https://openalex.org/W2270408419","https://openalex.org/W2332630894","https://openalex.org/W2334694951","https://openalex.org/W2901674645","https://openalex.org/W4285719527","https://openalex.org/W4298379398","https://openalex.org/W6628081623","https://openalex.org/W6639220086","https://openalex.org/W6677956934"],"related_works":["https://openalex.org/W2022535136","https://openalex.org/W1941542407","https://openalex.org/W2082319565","https://openalex.org/W1969192656","https://openalex.org/W2117686153","https://openalex.org/W2023720862","https://openalex.org/W2133988080","https://openalex.org/W2112393840","https://openalex.org/W68714234","https://openalex.org/W2081705684"],"abstract_inverted_index":{"A":[0],"phase":[1,51,145,156],"I/II":[2],"trial":[3],"was":[4,74,127,176,204,214,226,234],"undertaken":[5],"to":[6,21,46,142,160,209,219,224,238],"determine":[7],"the":[8,23,155,232],"maximum":[9,122],"tolerated":[10,123],"dose":[11,78,124,197],"of":[12,63,79,105,125,202,249],"polyethylene":[13],"glycol":[14],"interferon-alpha-2b":[15],"(PEG-IFN)":[16],"with":[17,29,42,182],"interleukin-2":[18],"(IL-2),":[19],"and":[20,25,70,103,138,186,190],"evaluate":[22],"efficacy":[24],"toxicity":[26,48,250],"in":[27,151,154,172],"patients":[28,131,153,175],"metastatic":[30],"renal":[31],"cell":[32],"carcinoma.":[33],"Patients":[34,55],"initially":[35],"received":[36,56],"subcutaneous":[37,72],"PEG-IFN,":[38],"3.0":[39,61],"mcg/kg/wk,":[40],"combined":[41],"IL-2,":[43],"but":[44],"owing":[45,237],"unexpected":[47],"a":[49,77],"revised":[50],"I":[52,146],"schedule":[53],"ensued.":[54],"1.0,":[57],"1.5,":[58],"2.0,":[59],"or":[60],"mcg/kg/wk":[62],"PEG-IFN":[64,126],"on":[65,89],"days":[66,99],"1,":[67,91,107],"8,":[68],"15,":[69],"22;":[71],"IL-2":[73],"given":[75],"at":[76,94,191,195],"5":[80,95,104,109],"x":[81,87,96],"10":[82,97],"IU/m2":[83,98],"every":[84],"8":[85],"hours":[86],"3":[88,114],"day":[90],"followed":[92,116],"daily":[93],"2,":[100],"3,":[101],"4,":[102],"week":[106,112],"then":[108],"times":[110],"per":[111],"for":[113,253],"weeks,":[115],"by":[117],"2":[118,183,208,218],"weeks":[119],"off.":[120],"The":[121,168,199],"2.0":[128],"mcg/kg/wk.":[129],"Fifty-four":[130],"were":[132],"enrolled.":[133],"Frequent":[134],"grade":[135],"III/IV":[136],"cardiac":[137],"neurologic":[139],"toxicities":[140],"led":[141,159],"an":[143,254],"expanded":[144],"trial.":[147],"Eleven":[148],"serious":[149,243],"events":[150,245],"33":[152],"II":[157],"portion":[158],"early":[161],"termination.":[162],"No":[163],"patient":[164],"died":[165],"from":[166],"treatment.":[167],"overall":[169],"response":[170,194,203],"rate":[171],"53":[173],"evaluable":[174],"30.2%":[177],"(95%":[178],"confidence":[179],"interval":[180],"20.5-39.9),":[181],"complete":[184],"responses":[185,189],"14":[187],"partial":[188],"least":[192],"1":[193],"each":[196],"level.":[198],"median":[200,212,222],"duration":[201],"11":[205],"months":[206,216],"(range,":[207,217],"65+":[210],"mo);":[211,221],"survival":[213],"20":[215],"71+":[220],"time":[223],"progression":[225],"4":[227],"months.":[228],"Despite":[229],"clinical":[230],"efficacy,":[231],"study":[233],"closed":[235],"prematurely":[236],"excess":[239],"toxicity.":[240],"Although":[241],"all":[242],"adverse":[244],"resolved,":[246],"this":[247],"degree":[248],"is":[251],"unacceptable":[252],"outpatient":[255],"treatment":[256],"regimen.":[257]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}